Other Clinical Applications and Results

Guy’s and St Thomas’s: Prostate Diagnostic Clinic – Routine use (post clinical trial)

As of May 2026, over 2800+ patients reviewed using Deontics Pathways IQ
Key Findings:

• Reduced diagnostic delays
• Clinician satisfaction
• Nurse and trainee doctors managing the clinic with help from Deontics CDS

Guy’s and St Thomas’s:  Breast Cancer Pathway – retrospective analysis 

250 patients reviewed using Deontics Pathways IQ.
Key Findings:

• Concordance with MDT improved from 82% to 100% in benign cases and 94% to 100% in cancer cases after iterative validation of Standard of Care
• Results in the process of being published

Royal Liverpool University Hospital – Colon Cancer Pathway – Pilot study (ongoing)

As of May 2026, 100 patients reviewed using Deontics Pathways IQ
Key Findings:

• 30% cases eligible for triaging out of full MDT discussion
• 100% concordance with MDT in triaged out patients

Royal Liverpool University Hospital – Rectal Cancer Pathway – Pilot study (ongoing)

As of May 2026, 33 patients reviewed using Deontics Pathways IQ
Key Findings:

• 100% concordance with MDT in triaged out patients

Bart’s Hospital – Lung Cancer Pathway – Pilot study (ongoing)

As of May 2026, 480+ patients reviewed using Deontics Pathways IQ
Key Findings:

• Clinical trial eligibility was flagged by Pathways IQ in 26 % cases vs MDT in 7 % cases.
• Concordance rate between Deontics recommendation MDT decisions = 91 %